ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Sees Large Growth in Short Interest

Posted by Chris Copeland on Jan 28th, 2025

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 41,800 shares, a growth of 305.8% from the December 31st total of 10,300 shares. Based on an average trading volume of 12,800 shares, the days-to-cover ratio is presently 3.3 days.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

BIS remained flat at $16.56 during trading hours on Tuesday. 6,178 shares of the company traded hands, compared to its average volume of 6,819. ProShares UltraShort Nasdaq Biotechnology has a fifty-two week low of $14.05 and a fifty-two week high of $21.10. The firm has a fifty day moving average price of $17.30 and a 200-day moving average price of $15.88.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were given a dividend of $0.2064 per share. The ex-dividend date was Monday, December 23rd. This is an increase from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

Institutional Trading of ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC purchased a new position in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the Securities and Exchange Commission.

ProShares UltraShort Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.